The Department of Pediatrics, Gynaecology and Obstretrics, University of Geneva in collaboration with the Department of Pharmacology, JIPMER, Puducherry is organizing a one-day symposium as part of the weeklong JIPMER Integrated Pharmacogenomics Program, JIPP-2019.
swissnex India along with Unige and JIPMER is organizing an “Indo-Swiss symposium on advances in pharmacogenomics strategies for implementation in personalized medicine” (Module 3). This symposium is oriented towards creating awareness on the topic of Pharmacogenomics and personalized medicine, applications of pharmacogenomics in various medical disciplines, recent advances in pharmacogenomics, with discussions and knowledge-sharing by several experts five Indian and three Swiss speakers.
A great opportunity to network and build your community involving medical students, practicing physicians, medical specialists, clinical pharmacists, pharmacy, and even allied health scientists!
Prof. Urs A. Meyer is one of the most renowned Swiss Clinical Pharmacologists, whose discoveries and scientific results have fundamentally contributed to clinical pharmacology and its development over the last 50 years. His research focused on interindividual variation in drug response, from the study of drug sensitivity of porphyria in the 1970’s (as a postdoc and then assistant professor in the US) to the, by then, emerging field of pharmacogenomics of drug disposition upon return to Switzerland in Basel in the 1980’s as a full professor. He is probably best known for the discovery of the molecular mechanisms of several common genetic polymorphisms of drug disposition. Focusing on human cytochrome P450 enzymes, he was one of the first to purify and clone CYP2D6 and CYP2C19 and to decipher their genetic variations. His sustained productivity has resulted in more than 340 original publications, reviews and book chapters. His achievements have been recognized with several awards and honors, and he has assumed numerous leadership roles at the international level including WHO and the NIH.
Professor of Pharmacology, Biozentrum / University of Basel
Dr. Daaly holds PhD in Clinical Pharmacology. Dr. Daaly wears many hats: he is a researcher with over 90 paper publications, 45 oral and poster presentations in prestigious International meetings, a patent, multiple awards for clinical research, and a reviewer for International Scientific Journals. He is currently the Head of the Clinical Research Laboratory of Pharmacology Service Geneva University Center. Dr.Youssef works in partnership with the pediatric onco-hematology platform of the University Centre of Geneva (laboratory of the CANSEARCH Foundation) in the areas of pediatric pharmacology.
Dr. Youssef Daaly
Head of the Laboratory of Clinical Pharmacology / HUG
Dr. Uppugunduri holds a PhD in Clinical Pharmacology. He works as Senior Researcher, Head of experimental research, at the CANSEARCH Research Laboratory. He is also a Teaching Assistant at the University of Geneva. He is a member of the educational division of the European Society of Pharmacogenomics and Personalized Therapy (ESPT). His research has focused on pharmacogenetics and personalized medicine. He is part of the group that works on personalizing chemotherapy and the conditioning regimens prior to stem-cell transplantation in children and adolescents. He is currently pursuing research projects focusing on the identification of pharmacogenetic information that can be used to improve the clinical care especially in pediatric onco-hematology.
Dr. Chakradhara Uppugunduri
Senior Researcher, and Head of experimental research / CANSEARCH
Dr. Marc Ansari studied medicine in Geneva, after a degree in biology and genetics in 1996. He obtained a doctor's degree in 2001, which he completed with a specialization in pediatrics (FMH in 2004). Back in Geneva, he obtained a specialization in pediatric onco-hematology in 2008 and joined the Pediatric Oncology-Hematology Unit of the HUG, which he led in 2013. His research interests focused on pharmacogenomics and personalized therapy in pediatric onco-hematology. He also works on neuroblastoma and various tumors of the child. Head of the pediatric hematology and oncology research platform of the Faculty of Medicine, he founded and directs the CANSEARCH Foundation with the aim of supporting its activities. Since 2014, he has been working in the European office of the pediatric group of the association.Blood and Marrow Transplantation as well as the European Society of Pharmacogenomics and Individualized Therapy. In 2016, he created and became head of the Swiss Group of Pharmacogenomics and Individualized Therapy. Privat-docent of the Faculty of Medicine of UNIGE in 2013, he was appointed Assistant Professor in the Department of Pediatrics in January 2016.
Dr. Marc Ansari
Member Founder and Director / CANSEARCH
Know more details on the schedule and sessions here.